6PS3
XFEL beta2 AR structure by ligand exchange from Timolol to Carvedilol.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | FREE ELECTRON LASER |
Source details | SACLA BEAMLINE BL3 |
Synchrotron site | SACLA |
Beamline | BL3 |
Temperature [K] | 293 |
Detector technology | CCD |
Collection date | 2015-05-19 |
Detector | MPCCD |
Wavelength(s) | 1.76 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 42.550, 77.440, 173.850 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 46.400 - 2.500 |
R-factor | 0.205 |
Rwork | 0.203 |
R-free | 0.24200 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3d4s |
RMSD bond length | 0.010 |
RMSD bond angle | 1.060 |
Data reduction software | CrystFEL |
Data scaling software | CrystFEL |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.400 | 2.630 |
High resolution limit [Å] | 2.500 | 2.500 |
Number of reflections | 20630 | 2811 |
<I/σ(I)> | 4.1 | |
Completeness [%] | 100.0 | |
Redundancy | 253.3 | |
CC(1/2) | 0.984 | 0.155 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 293 | 0.1 M HEPES pH 7.0, 0.1 M Ammonium Sulfate, 30% PEG 400, 2 mM of target ligand Carvedilol |